Indefinite Delivery Contract HHSO100201200014I

The Indefinite Delivery Contract (IDC) SPE2DR25D3026, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $9.99 billion single-award contract to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses a 30-month base period with three 30-month option periods, running through December 2036. As the prime vendor, Amerisourcebergen will be...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency, to Biocodex, Inc., a foreign-owned for-profit organization. The contract is a multiple-award vehicle under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a period of performance through April 30, 2026 and a ceiling value of $700,000.00. The contract is intended to provide the agency with a range of pharmaceutical and hematology-related products. While no specific task...

The National Prime Vendor contract will provide pharmaceutical products and related services to multiple TRICARE Mail Order Pharmacy and TRICARE Specialty Pharmacy Network ordering facilities in support of the Defense Health Agency's TRICARE Pharmacy Program. Amerisourcebergen Drug Corporation will serve as the prime vendor, delivering products from distribution centers including a location in Conshohocken, Pennsylvania. Delivery orders issued against the contract, valued at amounts ranging from...

The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...

This federal contract IDV award is for the supply of ranibizumab ophthalmic injections to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award indefinite delivery contract, valued at $11,392,063.40, was issued by the VA National Acquisition Center to the prime contractor Biogen U.S. Corporation, a for-profit pharmaceutical manufacturer. The contract has a performance period from December 23, 2023, through December 22, 2025, with four...

This federal contract IDV is a Multiple Award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Biogen U.S. Corporation, a pharmaceutical and biotechnology company. The contract has a ceiling value of $2,210,000,000 and a period of performance through September 14, 2026. Biogen has been awarded multiple firm-fixed-price delivery orders against this FSS contract to supply specialized pharmaceutical products to the VA, primarily through its Veterans...

The Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award indefinite delivery contract to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, with a total ceiling value of $27,898,886.92 and a period of performance through May 21, 2031. Under this contract, Genentech will provide a variety of pharmaceutical products and medical supplies to support the DLA's mission to procure and distribute critical healthcare resources for the U.S. Department of...

This Federal Supply Schedule contract was awarded by the National Acquisition Center, a civilian federal agency, to PTC Therapeutics US, Inc. as the prime contractor. The contract, valued at a ceiling of $225,000.00, is for the procurement of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. The contract has a period of performance from March 1, 2024 to February 28, 2029. Additionally, a $12,500.00 Blanket Purchase Agreement (BPA) was awarded under this IDV to PTC Therapeutics, Inc. for...

This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 to Acrotech Biopharma Inc., a foreign-owned for-profit organization. The contract is a multiple award under NAICS code 65 I B for "Drugs, Pharmaceuticals, & Hematology Related Products" with a ceiling value of $225,000.00 and a period of performance through February 14, 2026. The purpose of this contract is to provide pharmaceutical and drug products to the agency. The contract is...

This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a civilian agency, to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The BPA is for the drug Evrysdi, a treatment for spinal muscular atrophy, and has a ceiling value of $1,725,140.20. It was awarded on September 22, 2023 with an ultimate completion date of September 21, 2026. The BPA does not utilize any set-aside designations, indicating open competition. As a single-award...